CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Catalent Pharma Solutions, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Catalent Pharma Solutions, Inc.
14 Schoolhouse Rd
Phone: (732) 537-6200p:732 537-6200 Somerset, NJ  08873-1213  United States Fax: (732) 537-6480f:732 537-6480
This is a Subsidiary, click here for the Parent Company
Business Summary
Catalent Pharma Solutions, Inc. is a United States-based company provider of development solutions and advanced delivery technologies for drugs, biologics and consumer health products. The Company's brands include: OptiGel bio technology for macromolecule encapsulation; OptiShell technology for modified release; OptiGel lock technology for abuse deterrence; OptiGel micro technology for flexible dosing, and coated softgels.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
---YesYes--

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
--YesYes-YesYes

Industries
SIC Code Description
2834 Pharmaceutical preparations
8099 Health and allied services, not elsewhere classified
2833 Medicinal chemicals and botanical products
7389 Business services, not elsewhere classified
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President, Chief Executive Officer, Director John R.Chiminski 55 3/17/2009 3/17/2009
Chief Financial Officer, Senior Vice President Matthew M.Walsh 53 4/1/2008
President - Softgel Technologies DavidHeyens 56 6/11/2010 1/1/1995
12 additional Officers and Directors records available in full report.

Business Names
Business Name
Allcaps Weichgelatinekapseln GmbH & Co. KG
Allcaps Weichgelatinekapseln Verwaltungs GmbH
Catalent (Shanghai) Clinical Trial Supplies Co., Ltd.
45 additional Business Names available in full report.

General Information
Number of Employees: 8,300 (As of 6/30/2013)
Outstanding Shares: 100 (As of 3/31/2014)
Federal Tax Id: 133523163
Fax Number: (732) 537-6480
Email Address: info@catalent.com


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 5, 2024